Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Inflammation

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00918971PMID 1428121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA.

  1992cited by this paper
• Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis

  1991cited by this paper
• Acute lung injury induced by phospholipase A2. Structural and functional changes.

  1991cited by this paper
• Cloning of a phospholipase A2-activating protein.

  1991cited by this paper
• Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints.

  1991cited by this paper
• Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo.

  1990cited by this paper
• Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.

  1990cited by this paper
• Compartmental heterogeneity of soluble phospholipases A

  1990cited by this paper
• Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

  1989cited by this paper
• Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.

  1989cited by this paper
• Multiple forms of phospholipase A2 in arthritic synovial fluid.

  1989cited by this paper
• The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.

  1989cited by this paper
• Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis.

  1988cited by this paper
• Lipocortin and the mechanism of action of the glucocorticoids

  1988cited by this paper
• Modulation of phospholipase A2 activity in human synovial fluid by cations

  1987cited by this paper
• Pancreatic Phospholipase A2: Isolation of the Human Gene and cDNAs from Porcine Pancreas and Human Lung

  1986cited by this paper
• Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis.

  1986cited by this paper
• Role of secretory phospholipases A2 in the pathobiology of disease.

  1986cited by this paper
• Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2

  1986cited by this paper
• Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits.

  1986cited by this paper
• Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.

  1985cited by this paper
• Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid.

  1985cited by this paper
• Amino acid sequence of phospholipase A2-alpha from the venom of Crotalus adamanteus. A new classification of phospholipases A2 based upon structural determinants.

  1977cited by this paper

• Biomimetic phospholipid analogs for enzyme-resistant superlubrication

  2026cites this paper
• Discovery of a new Daboia russelli viper venom PLA2 inhibitor using virtual screening of pharmacophoric features of co-crystallized compound

  2023cites this paper
• Modulation of immunity by the secreted phospholipase A2 family

  2023cites this paper
• Old but New: Group IIA Phospholipase A2 as a Modulator of Gut Microbiota

  2022cites this paper
• Half is enough: Oxidized lysophospholipids as novel bioactive molecules.

  2022cites this paper
• Enhancing Extracellular Vesicles for therapeutic treatment of arthritic joints.

  2021cites this paper
• Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles

  2020cites this paper
• Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

  2020cites this paper
• Matrix vesicles: structure, composition, formation and function in calcification.

  2011cites this paper
• A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis

  2010cites this paper
• sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised.

  2009cites this paper
• Phospholipase A2 activity of crocodile serum

  2009cites this paper
• OF ANTIBIOTICS Isolation and Biological Activity of Thielocins : Novel Phospholipase A 2 Inhibitors Produced by Thielavia terricola RF-143

  2006cites this paper
• Phospholipase A2: quo vadis?

  2005cites this paper
• Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions.

  2001cites this paper
• Maintaining carotid flow by shunting during carotid endarterectomy diminishes the inflammatory response mediating ischaemic brain injury.

  2000cites this paper
• Type IIA Secretory Phospholipase A2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes1

  2000cites this paper
• Basic residues of human group IIA phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition comparison with other mammalian secreted phospholipases A2.

  2000cites this paper
• Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells.

  1999cites this paper
• Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.

  1999cites this paper
• Phospholipase A2: its usefulness in laboratory diagnostics.

  1999cites this paper
• Functional coupling and differential regulation of the Phospholipase A2‐cyclooxygenase pathways in inflammation

  1999cites this paper
• Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium

  1998cites this paper
• Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease.

  1997cites this paper
• Quantitation of human tissue and immune cell type II 14 kDa phospholipase A2 by enzyme immunoassay

  1997cites this paper
• Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of anti-inflammatory activity.

  1997cites this paper
• The synovial-like membrane at the bone interface in loose total hip replacements contains high levels of extracellular group II phospholipase A2.

  1996cites this paper
• Tenidap in rheumatoid arthritis: comment on the article by Blackburn et al.

  1996cites this paper
• Phospholipase A2 stimulation of rat intestinal epithelial cell (IEC-6) migration.

  1996cites this paper
• Induction of TNF-alpha and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis.

  1995cites this paper
• Synovial fluid lipids and apolipoproteins: A contemporary perspective

  1995cites this paper
• Isolation and biological activity of thielocins: novel phospholipase A2 inhibitors produced by Thielavia terricola RF-143.

  1995cites this paper
• Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

  1995cites this paper
• Development and use of ELISA to quantify type II phospholipase A2 in normal and uremic serum.

  1995cites this paper
• Inactivation of phospholipase A2 by naturally occurring biflavonoid, ochnaflavone.

  1994cites this paper
• Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.

  1994cites this paper
• Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides.

  1994cites this paper
• Thielocin B3, a novel antiinflammatory human group II phospholipase A2 specific inhibitor from ascomycetes.

  1994cites this paper
• Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

  1994cites this paper
• Group II phospholipase A2 in synovial fluid and serum in acute arthritis.

  1994cites this paper
• Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity.

  1994cites this paper
• Human group II phospholipase A2 expressed in Trichoplusia ni larvae--isolation and kinetic properties of the enzyme.

  1993cites this paper
• Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states.

  1993cites this paper
• Synovial fluid lipoproteins: review of current concepts and new directions.

  1993cites this paper